Alpha Teknova, Inc. (NASDAQ:TKNO) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) have been assigned an average recommendation of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $8.00.

A number of equities analysts recently issued reports on the stock. Weiss Ratings lowered shares of Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. Jefferies Financial Group began coverage on Alpha Teknova in a research report on Thursday. They issued a “buy” rating and a $9.00 target price for the company. Roth Capital began coverage on Alpha Teknova in a research note on Wednesday, August 5th. They set a “buy” rating and a $7.00 price target for the company. Wall Street Zen raised Alpha Teknova from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Zacks Research upgraded Alpha Teknova to a “hold” rating in a research report on Thursday, August 6th.

Alpha Teknova Price Performance

NASDAQ TKNO opened at $8.34 on Thursday. Alpha Teknova has a 52 week low of $1.91 and a 52 week high of $8.38. The company has a current ratio of 4.49, a quick ratio of 3.48 and a debt-to-equity ratio of 0.21. The stock has a market cap of $447.11 million, a price-to-earnings ratio of -26.90 and a beta of 0.72. The company has a 50-day moving average price of $6.49 and a two-hundred day moving average price of $4.79.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.02. Alpha Teknova had a negative return on equity of 24.94% and a negative net margin of 38.37%.The business had revenue of $12.19 million during the quarter, compared to the consensus estimate of $10.95 million. Analysts forecast that Alpha Teknova will post -0.28 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. ProShare Advisors LLC acquired a new position in shares of Alpha Teknova in the 4th quarter worth $38,000. Deutsche Bank AG acquired a new stake in shares of Alpha Teknova during the second quarter worth $62,000. Ieq Capital LLC purchased a new stake in shares of Alpha Teknova during the second quarter valued at $62,000. R Squared Ltd acquired a new position in shares of Alpha Teknova in the 1st quarter valued at $42,000. Finally, Susquehanna International Group LLP acquired a new position in shares of Alpha Teknova in the 2nd quarter valued at $115,000. 13.81% of the stock is owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

Alpha Teknova, Inc (NASDAQ: TKNO) develops and manufactures critical reagents and solutions used in life sciences research, biopharmaceutical development, and laboratory testing. The company supplies ready-to-use and custom-formulated biological buffers, media, process liquids, and other high-purity reagents designed to support research and production workflows.

Its products and services are used across applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development, and other genomics and bioprocessing activities.